We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NKE:NYSENike, Inc. Analysis

Data as of 2026-09-06 - not real-time

$38.40

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

NIKE, Inc. trades at $38.40, with its short-term moving averages sitting below the longer-term ones — a bearish trend structure. The last 30 days have lost 7.9%. With RSI at 40.1 the momentum picture is neutral, alongside a bearish MACD signal. Recent trading has carved out support near $37.95 and resistance around $42.23.
Multiples put this in fair territory at a P/E of 18.3. Analyst price targets sit 31.4% above the current price. The 4.27% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 5 — moderate. With 30-day volatility of 31.1%, a beta of 0.72 and a maximum drawdown of 48.9%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Near-term and long-term part ways here — sell short-term against hold longer out, with 2/10 conviction on the long call.

Top Market Events

Jennifer Saibil, The Motley Fool Thu, September 3, 2026 at 7:52 PM UTC 0 Image source: Nike It's dealing with several...Nike stock has dropped to the upper $38 range, hitting a 12-year low as the company navigates softerNIKE, Inc. NYSE:NKE raised its quarterly dividend from $0.40 to $0.41 in November 2025, a roughly 3% increase. That...

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 4/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 51.42
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 2/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 51.42
  • Analyst targets imply +31.4% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 2/10

Key Factors

  • Analyst targets imply +31.4% versus the current price
  • Revenue contracting at -1.1%
  • P/E ratio of 18.3

Key Metrics & Analysis

Financial Health

Revenue Growth-1.10%
Profit Margin6.70%
P/E Ratio18.3
ROE22.14%
ROA6.97%
Debt/Equity74.29
P/B Ratio3.8
Op. Cash Flow$2.9B
Free Cash Flow$1.9B

Technical Analysis

TrendBearish
RSI40.1
Support$37.95
Resistance$42.23
MA 20$39.83
MA 50$41.51
MA 200$51.42
MACDBearish
VolumeStable
Fear & Greed Index95.48

Valuation

Fair Value$14.76
Target Price$50.46
Upside/Downside31.40%
GradeFair
TypeValue
Dividend Yield4.27%

Risk Assessment

Beta0.72
Volatility31.12%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.